Respiri acquires Orb Health for $9 million to expand US healthcare market presence.
Posted on: 25/11/2024
Respiri Limited halts trading ahead of strategic acquisition news.
Posted on: 21/11/2024
AMA endorses changes to RPM reimbursement criteria, benefiting Respiri Limited.
Posted on: 04/11/2024
Respiri Limited sees revenue rise by 56.85% but reports a larger net loss for FY 2024.
Posted on: 27/08/2024
Respiri Limited secures $1.1 million from existing shareholders.
Posted on: 29/07/2024